TO · PRM.TO
Big Pharma Split Corp.
- Sector
- Financial Services · Asset Management
- Headquarters
- Oakville, ON L6j 4A5
- Website
- harvestportfolios.com
Price at previous close
$13.62
Market cap 16.84M
Valuation summary
Four models, one snapshot. Upside is target ÷ current − 1.
Valuation history
Annual price overlaid with each model's fair value. Y-axis is log scale.
| Year | Price | AI | DCF | Graham-Dodd | Graham Formula |
|---|---|---|---|---|---|
| 2011 | |||||
| 2012 | |||||
| 2013 | |||||
| 2014 | |||||
| 2015 | |||||
| 2016 | |||||
| 2017 | $6.05 | ||||
| 2018 | $6.36 | $1,497.03 | $35,840,684.61 | $0.00 | $1,381.04 |
| 2019 | $6.97 | $211.12 | $49.13 | $5.81 | $0.00 |
| 2020 | $8.54 | $693.31 | $1,190.17 | $0.00 | $8.95 |
| 2021 | $10.15 | $3,955.13 | $11,764.05 | $3.20 | $297.06 |
| 2022 | $10.50 | $993.97 | $183.74 | $0.00 | $0.00 |
| 2023 | $12.11 | $358.59 | $12.45 | $0.00 | $9.17 |
| 2024 | $12.27 | $1,544.61 |
About Big Pharma Split Corp.
Back to about heading
Big Pharma Split Corp is a closed ended equity mutual fund launched and managed by Harvest Portfolios Group Inc. It invests in the public equity markets across United States. The fund primarily invests in the Pharmaceutical sector. Big Pharma Split Corp was formed on September 15, 2017 and is domiciled in Canada.
- CEO
- Louis Michael Kovacs
- Employees
- 0
- Beta
- 0.69
Disclaimer: Information on this page is provided for educational purposes only and does not constitute investment advice. Upside computed as (— ÷ $13.62) − 1 = — (DCF, example).